Awards Nomination 20+ Million Readerbase
Indexed In
  • Academic Journals Database
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Ulrich's Periodicals Directory
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • Google Scholar
Share This Page
Journal Flyer
Journal of Bioequivalence & Bioavailability
Quantum dot- conjugated antibodies as diagnostic and therapeutic tools for cancer imaging and treatment
4th World Congress on Bioavailability and Bioequivalence: Pharmaceutical R&D Summit
May 20-22, 2013 DoubleTree by Hilton, Beijing, China

Weiming Xu

AcceptedAbstracts: J Bioequiv Availab

Abstract:

The conjugates of monoclonal antibodies and nanoparticles, including quantum-dot, have offer significant advantages over conventional fluorescent probes to image and study biological processes. The extend stability and low toxicity of QDs are well suited for biological applications. Despite this, the potential of Qdots remains limited owing to the inefficiency of existing delivery methods. By conjugating Qdots with small antibody fragments targeting membrane-bound proteins, such as GRP78, we demonstrated that the Quantum dot- Anti-GRP78 scFv (Qdot-GRP78) retains its immunospecificity and its distribution can be monitored by visualization of multi-color fluorescence imaging both in vitro and in vivo(1). Moreover we have shown for the first time that Qdot-GRP78 scFv bioconjugates can be efficiently internalized and possess biological anti-tumour activity in a breast cancer xenograft model. Given in a recent pioneering study using primates for Qdots toxicity study has shown that its nanocrystals to be safe over a one-year period(2), the nanocarrier-conjugated antibody fragment has potential to become a new therapeutic tool for cancer treatment.